ADPKD Clinical Trials in Brussels
2 recruitingBrussels, Belgium
Showing 1–2 of 2 trials
Recruiting
Phase 2
Phase 2a Study of VX-407 in Participants With ADPKD Who Have a Subset of PKD1 Gene Variants (AGLOW)
Autosomal Dominant Polycystic Kidney Disease (ADPKD
Vertex Pharmaceuticals Incorporated24 enrolled43 locationsNCT07161037
Recruiting
Phase 3
HYDROchlorothiazide to PROTECT Polycystic Kidney Disease Patients and Improve Their Quality of Life
ADPKD
University Medical Center Groningen300 enrolled12 locationsNCT05373264